2020
DOI: 10.2174/1570178616666190226144620
|View full text |Cite
|
Sign up to set email alerts
|

K2CO3 Promoted Cascade Reaction for the Preparation of 1H-Imidazol-4- yl-1-amine Derivatives

Abstract: : A K2CO3 promoted efficient one pot two-step method for the preparation of 1H-imidazol-4- yl-1-amine derivatives has been developed. A series of second amines with an imidazole group were obtained with 56%-91% yields by the K2CO3 promoted amination of acetates and nitrogen deprotection of the imidazole process.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…We selected 30 HPK1 inhibitors from literature and patents and assessed their affinity with HPK1 using MM/GBSA and Glids software (Figure S3 and Table S1). ,,, The correlation between MM/GBSA and Glids scores (Figure A) guided the selection of the top 10 inhibitors, which were then combined with the “linker + CRBN ligand” segment of SS47 , a HPK1 PROTAC that has been comprehensively evaluated to enhance tumor immunity, to create PROTACs P1–P10 (Figures S4 and S5). Predictions of the physicochemical properties of these assembled PROTACs using the ADMETlab 2.0 Web site (Table S2) indicated that PROTAC P10 exhibited more favorable characteristics (MW = 929.4, nRig = 49, nRing = 8, nRot = 22, TPSA = 211.89, nHD = 2) for oral absorption (Figure B).…”
Section: Resultsmentioning
confidence: 99%
“…We selected 30 HPK1 inhibitors from literature and patents and assessed their affinity with HPK1 using MM/GBSA and Glids software (Figure S3 and Table S1). ,,, The correlation between MM/GBSA and Glids scores (Figure A) guided the selection of the top 10 inhibitors, which were then combined with the “linker + CRBN ligand” segment of SS47 , a HPK1 PROTAC that has been comprehensively evaluated to enhance tumor immunity, to create PROTACs P1–P10 (Figures S4 and S5). Predictions of the physicochemical properties of these assembled PROTACs using the ADMETlab 2.0 Web site (Table S2) indicated that PROTAC P10 exhibited more favorable characteristics (MW = 929.4, nRig = 49, nRing = 8, nRot = 22, TPSA = 211.89, nHD = 2) for oral absorption (Figure B).…”
Section: Resultsmentioning
confidence: 99%